wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36655193-E830F586-34B4-42D8-B430-254A90095A48
Q36655193-E830F586-34B4-42D8-B430-254A90095A48
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36655193-E830F586-34B4-42D8-B430-254A90095A48
Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder.
P2860
Q36655193-E830F586-34B4-42D8-B430-254A90095A48
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36655193-E830F586-34B4-42D8-B430-254A90095A48
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c516a027680402c9d32a0afdad579cdba5447e0e
P2860
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.